D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
GE Vernova
GEV
|
$601M |
| 2 |
Walt Disney
DIS
|
$510M |
| 3 |
Palantir
PLTR
|
$502M |
| 4 |
Financial Select Sector SPDR Fund
XLF
|
$490M |
| 5 |
TSMC
TSM
|
$396M |
Top Sells
| 1 |
Boeing
BA
|
$967M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
$951M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
$567M |
| 4 |
Eli Lilly
LLY
|
$551M |
| 5 |
Arthur J. Gallagher & Co
AJG
|
$499M |
Sector Composition
| 1 | Technology | 20.32% |
| 2 | Healthcare | 13% |
| 3 | Consumer Discretionary | 12.32% |
| 4 | Financials | 8.62% |
| 5 | Industrials | 7.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
Dollar General
DG
$24.1B
| $65.1M | 0.06% |
740,545
-703,721
| -49% | -$61.9M |
|
|
HSAI
252
Hesai Group
HSAI
$3.52B
| $64.3M | 0.06% |
4,345,323
+3,674,923
| +548% | +$54.4M |
|
253
Liberty Live Group Series A
LLYVA
$8.63B
| $64.1M | 0.06% |
953,878
-8,509
| -0.9% | -$572K |
|
254
Axsome Therapeutics
AXSM
$6.25B
| $63.9M | 0.06% |
547,665
+527,319
| +2,592% | +$61.5M |
|
255
First Citizens BancShares
FCNCA
$24.9B
| $63.7M | 0.06% |
34,347
-2,653
| -7% | -$4.92M |
|
256
Affirm
AFRM
$28.4B
| $63.6M | 0.06% |
1,408,058
-1,734,883
| -55% | -$78.4M |
|
257
Edwards Lifesciences
EW
$47.5B
| $63.4M | 0.06% |
874,406
-102,412
| -10% | -$7.42M |
|
258
Molina Healthcare
MOH
$9.47B
| $63M | 0.06% |
191,329
-27,550
| -13% | -$9.07M |
|
259
BlackBerry
BB
$2.31B
| $62.6M | 0.06% |
16,610,351
+10,657,317
| +179% | +$40.2M |
|
260
Applovin
APP
$166B
| $62.4M | 0.06% |
235,389
-1,205,728
| -84% | -$319M |
|
261
PTC
PTC
$25.6B
| $62.3M | 0.06% |
402,303
+83,255
| +26% | +$12.9M |
|
262
Life Time Group Holdings
LTH
$6.38B
| $62.1M | 0.06% |
2,056,864
+2,026,596
| +6,696% | +$61.2M |
|
263
Cboe Global Markets
CBOE
$24.3B
| $61.2M | 0.05% |
270,728
+139,932
| +107% | +$31.6M |
|
264
Globe Life
GL
$11.3B
| $61.1M | 0.05% |
464,104
-215,675
| -32% | -$28.4M |
|
265
Capital One
COF
$142B
| $61M | 0.05% |
340,409
+270,295
| +386% | +$48.5M |
|
266
Diageo
DEO
$61.3B
| $60.8M | 0.05% |
580,192
+560,262
| +2,811% | +$58.7M |
|
267
Trane Technologies
TT
$92.1B
| $60.5M | 0.05% |
179,529
+140,430
| +359% | +$47.3M |
|
268
Kinder Morgan
KMI
$59.1B
| $60.1M | 0.05% |
2,105,938
+1,694,781
| +412% | +$48.4M |
|
269
Vistra
VST
$63.7B
| $59.6M | 0.05% |
507,097
+501,397
| +8,796% | +$58.9M |
|
270
W.W. Grainger
GWW
$47.5B
| $58.4M | 0.05% |
59,134
+17,620
| +42% | +$17.4M |
|
|
PCG.PRX
271
PG&E Corporation 6.000% Series A Mandatory Convertible Preferred Stock
PCG.PRX
$1.27B
| $58.4M | 0.05% |
1,325,000
-275,000
| -17% | -$12.1M |
|
272
LPL Financial
LPLA
$26.6B
| $58.3M | 0.05% |
178,183
-6,375
| -3% | -$2.09M |
|
273
Upstart Holdings
UPST
$6.44B
| $56.3M | 0.05% |
1,223,923
-2,063,836
| -63% | -$95M |
|
274
Pacira BioSciences
PCRX
$1.19B
| $56.3M | 0.05% |
2,263,909
+6,435
| +0.3% | +$160K |
|
275
Insmed
INSM
$30.7B
| $56.1M | 0.05% |
734,880
+226,093
| +44% | +$17.2M |
|